Cybin (HELP) Receivables (2021 - 2025)

Cybin (HELP) reported Receivables of $4.1 million for Q1 2025, up 23.47% on a YoY basis from $3.3 million in Q1 2024, and up 23.47% quarter-over-quarter from $3.3 million in Q1 2024.

Cybin (HELP) Receivables (2021 - 2025) Analysis & Trends

Cybin has reported Receivables for 3 years, with the latest figure at $4.1 million in Q1 2025.

  • For the quarter ending Q1 2025, Receivables rose 23.47% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2025 stood at $4.1 million (up 23.47% YoY), and the FY2025 full-year result was $4.2 million, up 27.45% from the prior year.
  • Receivables for Q1 2025 stood at $4.1 million, up from $3.3 million in the prior quarter.
  • The five-year high for Receivables was $4.1 million in Q1 2025, with the low at $1.1 million in Q1 2021.
  • Historically, Receivables has averaged $2.8 million across 3 years, with a median of $3.3 million in 2024.
  • The largest YoY upside for Receivables was 23.47% in 2025 against a maximum downside of 23.47% in 2025.
  • Cybin's Receivables stood at $1.1 million in 2021, then surged by 216.34% to $3.3 million in 2024, then increased by 23.47% to $4.1 million in 2025.
  • The last three Receivables figures came in at $4.1 million (Q1 2025), $3.3 million (Q1 2024), and $1.1 million (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 13.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.00 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Cybin 75.42 Mn 75.42 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 4.10 Mn
Mar 31, 2024 3.32 Mn
Mar 31, 2021 1.05 Mn